Evaluation of Safety of Thiosonide in Multiple Doses in Patients with Multidrug, Pre-extensively or Extensively Drug-Resistant Pulmonary Tuberculosis: a Multicenter Randomized Controlled Study | Savchenko | Tuberculosis and Lung Diseases

Tuberculosis and Lung Diseases
Tuberkulez i bolezni lëgkih

ISSN 2075-1230 (Print)
ISSN 2542-1506 (Online)

eng | рус

Preview

Tuberculosis and Lung Diseases

Advanced search

Archives

Download this PDF file

For citations:

Savchenko A.Yu., Burenkov M.S., Balakin E.I. Evaluation of Safety of Thiosonide in Multiple Doses in Patients with Multidrug, Pre-extensively or Extensively Drug-Resistant Pulmonary Tuberculosis: a Multicenter Randomized Controlled Study. Tuberculosis and Lung Diseases. 2025;103(4):75-81. (In Russ.) https://doi.org/10.58838/2075-1230-2025-103-4-75-81

Views PDF (Rus): 1

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 License.

ISSN 2075-1230 (Print)
ISSN 2542-1506 (Online)

* not an advertisement

Indexing Databases

* not an advertisement

Popular articles

Editor-in-Chief

IRINA A. VASILYEVA

Article Tools

Finding References

Email this article (Login required)

Email the author (Login required)

About the Authors

A. Yu. Savchenko
Research Center for Biomedical Technologies by the Federal Medical Biological Agency
Russian Federation

Alla Yu. Savchenko, Candidate of Medical Sciences, Leading Researcher of Pharmacosimulation Laboratory

1 Svetlye Gory Village, Krasnogorskiy District, Moscow Region, Russia, 143442

M. S. Burenkov
AO Pharm-Sintez
Russian Federation

Mikhail S. Burenkov, Candidate of Biological Sciences, Manager on Pre-Clinical Studies

2 Build. 46, 2nd Kabelnaya St., Moscow, 111024

E. I. Balakin
AO Pharm-Sintez
Russian Federation

Evgeniy I. Balakin, Candidate of Medical Sciences, Director for Drug Development

2 Build. 46, 2nd Kabelnaya St., Moscow, 111024

Notifications